share_log

港股异动 | 药明巨诺-B(02126)急升逾7% 国内首部《自体CAR-T细胞药品供应链管理规范》昨日起实施

Changes in Hong Kong stocks | Pharmaceutical Giant Nuo-B (02126) soared by more than 7%. China's first "autologous CAR-T cell drug supply chain management specification" was implemented yesterday.

智通財經 ·  Oct 19, 2021 13:54

Zhitong Financial APP learned thatYao Ming Junuo-B (02126)It surged more than 7% in the afternoon and rose 7.08% to HK $15.42 as of press time, with a turnover of HK $34.5424 million.

On the news side, on October 13, 2021, the National Group Information platform released the group standard of "autologous CAR-T cell drug supply chain management specification" (T/SHPPA 011mur2021), which was organized and drafted by Shanghai Pharmaceutical Industry Association and Shanghai Drug Evaluation and Verification Center. The standard has been implemented since October 18, 2021, which makes up for the gaps in the technical requirements and testing field of domestic autologous CAR-T cell drug supply chain management specification.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment